Zosano Pharma Corp. (fka ZSANQ)

[Monroe1]

Zosano Pharma Shares Drop 14% After Pricing Direct Offering >ZSAN
BY Dow Jones & Company, Inc.
— 12:34 PM ET 03/05/2020

Zosano Pharma Corp. ( ZSAN ) shares slid 14% to 76 cents after the company said it has agreed with institutional investors for the issuance and sale in a registered direct offering of 11.9 million of common stock and warrants to buy up to 11.9 million shares of common stock, at a combined purchase price of 92.75 cents a share.

The biopharmaceutical company said it expects gross proceeds of $11 million.

The offering is expected to close on or about March 6.

Zosano said it intends to use the net proceeds from the offering for pre-commercialization activities and for general working capital and corporate purposes.


LOOKS LIKE 92 Centavos WILL BE A NEW RESISTANCE. THE COMPANY IS MOVING FORWARD.